Holen Sie sich die Stockscreener-App
2.17
1.40%
0.03
Annexon Inc Aktie (ANNX) Neueste Nachrichten
Annexon Inc. Sees Relief Buying After Extended Drop2025 Macro Impact & Growth Focused Stock Reports - newsyoung.net
How to forecast Annexon Inc. trends using time series2025 Market Sentiment & Stepwise Entry and Exit Trade Signals - Newser
What moving averages say about Annexon Inc.July 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - Newser
Developing predictive dashboards with Annexon Inc. dataMarket Trend Report & AI Enhanced Trading Signals - Newser
Is Annexon Inc. stock reversal real or fake2025 Risk Factors & Consistent Profit Trading Strategies - Newser
How hedge fund analytics apply to Annexon Inc. stockCEO Change & Weekly Market Pulse Updates - Newser
Will Annexon Inc. see short term momentumQuarterly Market Summary & Risk Managed Investment Strategies - Newser
How to use a screener to detect Annexon Inc. breakoutsQuarterly Trade Summary & Fast Entry High Yield Tips - Newser
Strategies to average down on Annexon Inc.2025 Growth vs Value & Daily Volume Surge Trade Alerts - Newser
Using AI based signals to follow Annexon Inc.2025 Pullback Review & Weekly Market Pulse Alerts - Newser
Will breakout in Annexon Inc. lead to full recoveryJuly 2025 Intraday Action & Growth Focused Entry Point Reports - Newser
Can you recover from losses in Annexon Inc.2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - Newser
Can volume confirm reversal in Annexon Inc.Quarterly Trade Summary & Advanced Swing Trade Entry Alerts - Newser
Analysts Offer Insights on Healthcare Companies: Protara Therapeutics (TARA), Annexon Biosciences (ANNX) and Agilent (A) - The Globe and Mail
Applying Wyckoff theory to Annexon Inc. stockDividend Hike & Expert Approved Momentum Trade Ideas - Newser
Equity Incentive Trends in Biotech: Assessing Annexon's Recent Grant and Its Implications for Talent Retention and Growth - AInvest
Annexon Reports Inducement Grant to New Employee Under Nasdaq Li - GuruFocus
Annexon reports inducement grant to new employee under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
60,000 Share Options at $2.44: Annexon Grants Inducement Award Under Nasdaq Employment Plan - Stock Titan
Will Annexon Inc. stock go up soon2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - Newser
Annexon Reports Q2 2025 Earnings Miss, Spikes Short-Term Gains Amid Volatility - AInvest
What makes Annexon Inc. stock attractive to long term investors2025 Momentum Check & Weekly Sector Rotation Insights - Newser
Annexon Inc's Q2 2025 EPS Beats Estimates, with Robust Cash Position and Strong Pipeline Progress - AInvest
Will Annexon Inc. benefit from macro trendsQuarterly Market Summary & Free High Accuracy Swing Entry Alerts - Newser
Signal strength of Annexon Inc. stock in tech scannersEarnings Growth Report & Risk Controlled Daily Plans - Newser
Will Annexon Inc. rebound enough to break evenPortfolio Update Summary & Free Weekly Watchlist of Top Performers - Newser
Using RSI to spot recovery in Annexon Inc.Market Weekly Review & Daily Volume Surge Signals - Newser
What machine learning models say about Annexon Inc.Weekly Stock Analysis & Free Weekly Watchlist of Top Performers - Newser
Is Annexon Inc. stock risky to hold nowMarket Movers & Risk Managed Trade Strategies - newsyoung.net
How Interest Rate Changes Impact Annexon Inc. Stock PerformanceGold Moves & Growth Focused Stock Pick Reports - Newser
Annexon Misses Q2 Earnings, Drives Short-Term Gains Amid Biotech Sector Resilience - AInvest
HC Wainwright Reaffirms “Buy” Rating for Annexon (NASDAQ:ANNX) - Defense World
Trend analysis for Annexon Inc. this weekJuly 2025 Retail & Technical Pattern Alert System - Newser
Annexon Biosciences Faces Financial Risks Amid Global Trade Challenges - MSN
Price momentum metrics for Annexon Inc. explainedBull Run & Safe Capital Growth Plans - Newser
Why Annexon Inc. stock attracts strong analyst attentionMarket Trend Review & Fast Gain Stock Tips - thegnnews.com
Applying sector rotation models to Annexon Inc.Portfolio Return Report & Low Volatility Stock Recommendations - Newser
Annexon Biosciences Receives Buy Rating and $14 Price Target from Wells Fargo Analyst - AInvest
Promising Outlook for Annexon Biosciences: Buy Rating Backed by Strong Pipeline and Financial Stability - TipRanks
Annexon Biosciences Reports Q2 2025 Financial Results - TipRanks
Regression Model Predicts Rangebound Movement in Annexon Inc.2025 Geopolitical Influence & Risk Controlled Stock Alerts - sundaytimes.kr
Annexon's Path to Commercialization: Assessing Clinical Milestones and Financial Viability in a High-Risk, High-Reward Biotech Play - AInvest
Annexon Narrows Loss in Fiscal Q2 - The Globe and Mail
Annexon Biosciences Q2 GAAP EPS of -$0.34 Beats Estimates - AInvest
Annexon Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Annexon reports Q2 EPS (34c), consensus (36c) - TipRanks
Annexon's Strategic Momentum in 2025: Near-Term Catalysts and Long-Term Value Creation - AInvest
Annexon Reports Q2 2025 Financial Results and Highlights Portfolio Progress, Anticipated Milestones for Tanruprubart, Vonaprument, and ANX1502 - AInvest
Annexon Reports Second Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones - GlobeNewswire
How Annexon Inc. stock performs during market volatilityAnalyst Downgrade & Safe Capital Growth Plans - Newser
What makes Annexon Inc. stock price move sharplyPortfolio Update Summary & Stepwise Swing Trade Plans - Newser
Momentum divergence signals in Annexon Inc. chartQuarterly Portfolio Report & Consistent Growth Equity Picks - Newser
Can Annexon Inc. lead its sector in growthMarket Risk Summary & Weekly Top Gainers Trade List - 선데이타임즈
Can Annexon Inc. recover in the next quarter2025 Winners & Losers & AI Driven Stock Reports - Newser
Is Annexon Inc. stock a growth or value playFree Stock Market Watch With Alerts - Newser
1.55%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):